Asia's first industrial insect company Nutrition Technologies closes US$20m equity round
Chemical

Asia's first industrial insect company Nutrition Technologies closes US$20m equity round

Nutrition Technologies will use the fund on an expansion into new markets, launch new products, accelerate R&D; and create new strategic partnerships.

  • By ICN Bureau | September 21, 2022

Nutrition Technologies completed an equity venture round of US$ 20m. The round was led by PTT Ventures and supported by Sumitomo Corporation, ING Sustainable Investments, Mandala Capital, as well as continued participation from existing investors: Openspace Ventures, SEEDs Capital and Hera Capital. The round was advised by ING Corporate Finance. The proceeds will be used to fund an expansion into new markets; launch new products; accelerate R&D; and create new strategic partnerships.

"Aside from growth in clean-energy, PTT is expanding its portfolio into new businesses corresponding to global trends, sustainability, and social responsibility. We look forward to partnering with Nutrition Technologies to support their next phase of growth. Commercial insect protein production is one of the most important innovations of the past few years, with the potential to disrupt the animal feed and fertiliser sectors and solve multiple issues the world is currently facing. Furthermore, we expect this partnership will provide customers with innovative solutions to revolutionise the agriculture sector as well as improve people's quality of life" said Dr. Buranin Rattanasombat, Senior Executive Vice President, Innovation and New Ventures, PTT Public Company Limited.

 "We are very excited to partner with Nutrition Technologies, an innovative company that has superior technology to produce sustainable protein. We believe insect protein is one of the most important recent solutions to protein production, contributing to solving various environmental issues and addressing several Sustainable Development Goals (SDGs). We will utilize our business platform and customer network to promote and expand the BSF derived products" said Masahito Uno, GM Life Science Division, Sumitomo Corporation.

"Nutrition Technologies fits well in the investment strategy and portfolio of ING Sustainable Investments, as we seek to assist sustainable companies in scaling their operations. Together with our consortium partners we are also keen to support the company in capitalising on various opportunities in the fast-growing European and Asian markets of alternative proteins" said Mark Weustink, Head of ING Sustainable Investments.

"Nutrition Technologies has led the way in delivering black soldier fly solutions at scale and at a price that is competitive on the global markets. It means they are already providing a viable alternative to existing and less sustainable feed options. In achieving that, the team has demonstrated exceptional executional capabilities. Going forward, we have high conviction in their expansion plans" said Hian Goh, Founding Partner, Openspace Ventures.

"It is great to welcome our new investors, who collectively bring vast expertise and experience to help us realise our vision. We are also humbled by the continued support provided from our existing shareholders." said Tom Berry, Co-CEO and Co-founder, Nutrition Technologies.

The insect sector has gathered increasing attention over the past few years, with the global insect protein market alone estimated to be worth US$343 million in 2021, and expected to grow with a CAGR of 26.49% to reach US$1.3 billion by 2027. As a sustainable solution to help minimise multiple unsustainable practices, the sector as a whole has seen investments totalling nearly US$1 billion, but with multiple technological hurdles, few companies are yet to reach industrial scale, let alone profitability.

"Insects represent a virtually unlimited and untapped pool of biological assets, with huge opportunities for value creation. Tackling food security is only the tip of the iceberg and with our strengthened balance sheet, great partners and best in class IP, we are strategically positioned to lead the next agricultural revolution." said Richard Hayler, CFO, Nutrition Technologies.

Since 2015, Singaporean agri-biotech company, Nutrition Technologies, has been creating a commercial replica of the natural decomposition process, using their proprietary growth inoculants and black soldier flies (Hermetia illucens) to turn low-grade crop & food waste into highly sought after animal feed ingredients and biofertilisers.

“We are increasing production to meet market demand and providing essential ingredients to the domestic agricultural sector as well as boosting exports through shipping our products to Korea, Japan, Indonesia, Thailand, Vietnam, Philippines and Chile. We will also commence shipments to the UK and EU very soon." said Nick Piggott, Co-CEO and Co-founder, Nutrition Technologies.

Nutrition Technologies' production facilities are a result of over seven years of R&D and their strategic location in the tropics helps to optimise productivity and lower costs. Their proprietary technologies and vertical insect production system are designed to capitalise on the low-energy benefits and suitability of a tropical climate. Their team developed the entire production system, which uses some bespoke automated equipment to ensure strict biosafety, zero-waste and strong unit economics. Through avoided emissions, their products have great potential to help meet global climate change targets.

Nutrition Technologies has been doubling down on its success in commercialising insect-microbe systems and their approach to protecting that intellectual property has been lauded by IP experts and publications. "We have had some incredibly exciting breakthroughs over the past two years. Following successful additions to our patent portfolio, we will launch two new revolutionary biological products to the fertiliser market that will address some of the region's greatest challenges in crop productivity." said Martin Zorrilla, Nutrition Technologies.  

Nutrition Technologies will use these funds to further expand production capacity both at its current operating plant in Malaysia as well as through a new joint-venture project in a soon-to-be-announced second country in Southeast Asia.

The Company also intends to expand its R&D capabilities in Singapore; commence commercial activities in the UK and EU; and add several new patents to its existing IP portfolio.

"We believe our technological developments can help address some of the world's most critical problems and are highly motivated to accelerate expansion as quickly as possible. Our novel microbiology solution to insect production allows us to use a wide pool of raw materials which negates the most significant barrier to scaling." said Charlie Carter, COO, Nutrition Technologies.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization